Loading...
Equity in HTA: what doesn’t get measured, gets marginalised
When making recommendations about the public funding of new health technologies, policy makers typically pay close attention to quantitative evidence about the comparative effectiveness, cost effectiveness and budget impact of those technologies – what we might call “efficiency” criteria. Less atten...
Na minha lista:
| Udgivet i: | Isr J Health Policy Res |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5502411/ https://ncbi.nlm.nih.gov/pubmed/28694961 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13584-017-0162-3 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|